Skip to main content

中美冠科宣布高层领导变动

Written by Customer Service on . Posted in Public Companies.

加州圣地亚哥, April 15, 2020 (GLOBE NEWSWIRE) — 中美冠科宣布任命Jean-Pierre Wery博士为董事会执行主席，立即生效。Wery博士还将担任中美冠科母公司JSR生命科学有限责任公司 (JSR Life Sciences, LLC) 的首席技术官(CTO)。
JSR于2018年收购了中美冠科，这是迄今为止最大的以生命科学为重点的收购。在这个新的角色中，Wery博士将领导JSR生命科学公司的协作工作，以确定战略协同效应，并为药物和生物标记物研究开发创新技术、平台和工具。这一领导层变动确保了中美冠科和JSR生命科学家族公司之间的加强合作，以扩大其已经处于领先地位的生命科学领域。中美冠科也很高兴地宣布任命Armin Spura博士接替Wery博士担任首席执行官，自2020年4月1日起生效。作为首席执行官，Spura博士将推动中美冠科的全球企业战略，进一步加强公司在肿瘤、代谢性疾病和炎症等临床前研究服务领域的领先地位。“我已经接受并享受了中美冠科成长为世界领先的、全球临床前CRO所有的各种挑战，”Wery博士说。“现在是时候把控制权交给Armin，由他来带领公司进入下一个创新和成长时期了。”中美冠科是一个行业领先的医药服务外包（CRO）公司，在药物研发和生物标记物发现领域，在亚洲，美国及欧洲的每个分公司，拥有一系列的创新产品服务。中美冠科目前全球雇员超过700人。Spura博士说：“我很高兴加入中美冠科，并继承冠科开创性的发展模式，为我们的客户开发新的解决方案。”。“我相信中美冠科在临床前CRO领域具有独特的创新性，创新将继续是我们增长和市场领导地位的核心。”关于中美冠科中美冠科是JSR生命科学公司，是一家全球药物发现和开发服务公司，为推进肿瘤、炎症和代谢疾病研究提供转化平台。凭借广泛的相关模型和预测工具组合，中美冠科为客户提供优秀的临床候选药物。欲知详情，请访问：https://www.crownbio.comhttps://www.jsrlifesciences.comMedia Enquiries:Jody Barbeau
Crown Bioscience Inc.
pr@crownbio.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.